Table 2 Comparison of serum chloride concentration and chloride administration between survivors and non-survivors
Survivors (n = 89) | Non-survivors (n = 9) | p value | |
|---|---|---|---|
Cl on Pre-POD, meq/L (IQR) | 104 (102, 106) | 100 (95, 106) | 0.06 |
Cl on POD 1, meq/L (IQR) | 104 (102, 106) | 98 (96, 104) | 0.02 |
Cl on POD 2, meq/L (IQR) | 103 (100, 105) | 100 (95, 103) | 0.03 |
Total volume of intravenous fluid administration, mL (IQR) | 4,175 (3,660, 4,875) | 4,180 (2,070, 5,141) | 0.30 |
Sum of intravenous chloride administration, meq (IQR) | 314 (246, 386) | 289 (113, 476) | 0.33 |
Average chloride concentration in intravenous fluid, meq/L (IQR) | 76 (67, 83) | 69 (53, 93) | 0.61 |
Use of furosemide, n (%) | 16 (18) | 2 (22) | 0.75 |